Regeneron Pharmaceuticals, Inc.,, United States
Disclosure information not submitted.
3C-06 - Mortality and hospitalization rates of adults with stable, chronic heart failure with reduced ejection fraction in the US, a claims analysis to inform clinical trial background rates
Monday, August 25, 20258:50 AM - 8:55 AM ET
